Semantic Scholar uses AI to extract papers important to this topic.
Phase 1 study of APTO-253 HCl, an inducer of KLF4, in patients with advanced or metastatic solid tumors
- Investigational New Drugs
Introduction This phase I, multicenter, open-label, single-arm, dose-escalation study evaluated the safety, pharmacokinetics and… (More)
Is this relevant?